Chancellor visits White City
C hancellor Rachel Reeves and Minister for Pensions Emma Reynolds visited Quell Therapeutics, a biotechnology spinout based in Imperial’s Translation and Innovation Hub (I-HUB) at White City. They were also joined by Steve Bates OBE, CEO of UK Bioindustry Association, and Kristin Macleod CBE, Chief Strategy Officer of British Business Bank.
The Chancellor toured Quell’s lab facilities and spoke on the UK Government’s plans regarding pension funds ahead of her Mansion House Speech on Thursday 14th November. Quell Therapeutics is a biotech company that aims to create treatment for immune–mediated and inflammatory diseases using Tregs (a type of regulatory white blood cell). Earlier this year, Science Minister Dr Peter Kyle visited White City campus’ I-HUB after the launch of the government’s Regulatory Innovation Office, a key manifesto promise of the Labour government that aims to “reduce the burden for businesses hoping to bring new products and services to the market in some of the UK’s fastest-growing sectors through innovation,” according to a government press release.
